Does L-carnitine improve endothelial function in hemodialysis patients?

Journal of Research in Medical Sciences

Volumn 17, Issue 5, 2012, Pages 417-421

  Sabri, Mohammad Reza ^a   Fahimi, Farnaz ^b   Hajialiasgar, Soheila ^b   Etminan, Abbas ^b   Nazemi, Sarir ^b   Salehi, Farzaneh ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carotid intima media thickness; Chronic renal failure; Endothelial dysfunction; Flow mediated dilation; L carnitine

Indexed keywords

CARNITINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; PLACEBO;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MALE; MULTICENTER STUDY; NAUSEA AND VOMITING; RANDOMIZED CONTROLLED TRIAL; VASODILATATION;

EID: 84862669673     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Campean V, Neureiter D, Varga I, Runk F, Reiman A, Garlichs C, et al. Atherosclerosis and vascular calcification in chronic renal failure. Kidney Blood Press Res 2005; 28(5-6): 280-9.
2. Segal MS, Baylis C, Johnson RJ. Endothelial health and diversity in the kidney. J Am Soc Nephrol 2006; 17(2): 323-4.
3. Kocaman O, Oflaz H, Yekeler E, Dursun M, Erdogan D, Demirel S, et al. Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant poly- cystic kidney disease. Am J Kidney Dis 2004; 43(5): 854-60.
4. Santoro D, Bellinghieri G, Conti G, Pazzano D, Satta E, Costantino G, et al. Endothelial dysfunction in chronic renal failure. J Ren Nutr 2010; 20(5 Suppl): S103-S108.
5. Woo KS, Chook P, Yu CW, Sung RY, Qiao M, Leung SS, et al. Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation 2004; 109(16): 1981-6.
6. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26(5): 1235-41.
7. Scaglia F. Carnitine deficiency [Online]. 2010. [cited 2010 Apr 13]; Available from: URL: http://emedicine.medscape.com/article/942233-overview.
8. Guarnieri G, Situlin R, Biolo G. Carnitine metabolism in uremia. Am J Kidney Dis 2001; 38(4 Suppl 1): S63-S67.
9. Alvarez de SM, Bueno R, Perez-Guerrero C, Herrera MD. Effect of L-carnitine and propionyl-L-carnitine on endothelial function of small mesenteric arteries from SHR. J Vasc Res 2007; 44(5): 354-64.
10. Sayed-Ahmed MM, Khattab MM, Gad MZ, Mostafa N. Lcarnitine prevents the progression of atherosclerotic lesions in hypercholesterolaemic rabbits. Pharmacol Res 2001; 44(3): 235-42.
11. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39(2): 257-65.
12. Loffredo L, Marcoccia A, Pignatelli P, Andreozzi P, Borgia MC, Cangemi R, et al. Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease. Eur Heart J 2007; 28(5): 608-12.
13. Stasi MA, Scioli MG, Arcuri G, Mattera GG, Lombardo K, Marcellini M, et al. Propionyl-L-carnitine improves postischemic blood flow recovery and arteriogenetic revascularization and reduces endothelial NADPH-oxidase 4-mediated superoxide production. Arterioscler Thromb Vasc Biol 2010; 30(3): 426-35.
14. McMackin CJ, Widlansky ME, Hamburg NM, Huang AL, Weller S, Holbrook M, et al. Effect of combined treatment with alpha-Lipoic acid and acetyl-L-carnitine on vascular function and blood pressure in patients with coronary artery disease. J Clin Hypertens (Greenwich) 2007; 9(4): 249-55.
15. Volek JS, Judelson DA, Silvestre R, Yamamoto LM, Spiering BA, Hatfield DL, et al. Effects of carnitine supplementation on flow-mediated dilation and vascular inflammatory responses to a high-fat meal in healthy young adults. Am J Cardiol 2008; 102(10): 1413-7.
16. Silvestro A, Schiano V, Bucur R, Brevetti G, Scopacasa F, Chiariello M. Effect of propionylcarnitine on changes in endothelial function and plasma levels of adhesion molecules induced by acute exercise in patients with intermittent claudication. Angiology 2006; 57(2): 145-54.
17. Evans AM, Fornasini G. Pharmacokinetics of L-carnitine. Clin Pharmacokinet 2003; 42(11): 941-67.
18. Schreiber B. Safety of oral carnitine in dialysis patients. Semin Dial 2002; 15(1): 71-2.
19. Shahin Y, Khan JA, Samuel N, Chetter I. Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a metaanalysis of randomised controlled trials. Atherosclerosis 2011; 216(1): 7-16.
20. Stephens FB, Constantin-Teodosiu D, Laithwaite D, Simpson EJ, Greenhaff PL. Insulin stimulates L-carnitine accumulation in human skeletal muscle. FASEB J 2006; 20(2): 377-9.
21. Bloomer RJ, Smith WA, Fisher-Wellman KH. Glycine propionyl-L-carnitine increases plasma nitrate/nitrite in resistance trained men. J Int Soc Sports Nutr 2007; 4: 22.